IBD metabonomics predicts phenotype, disease course, and treatment response

Metabonomics in inflammatory bowel disease (IBD) characterizes the effector molecules of biological systems and thus aims to describe the molecular phenotype, generate insight into the pathology, and predict disease course and response to treatment. Nuclear magnetic resonance (NMR) spectroscopy, mas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjerrum, Jacob T., Wang, Yulan L., Seidelin, Jakob B., Nielsen, Ole H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379620/
https://www.ncbi.nlm.nih.gov/pubmed/34419930
http://dx.doi.org/10.1016/j.ebiom.2021.103551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379620/
https://www.ncbi.nlm.nih.gov/pubmed/34419930
http://dx.doi.org/10.1016/j.ebiom.2021.103551

Ejemplares similares